Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Heska Corp Announces Sale Of Non-Core Assets To Eli Lilly and Co's Division

Monday, 24 Jun 2013 09:00am EDT 

Heska Corp announced the sale of certain non-core assets useful for the production of both bovine and feline vaccines to Elanco Animal Health, a division of Eli Lilly and Co. Heska does not anticipate any change in its current bovine and feline vaccine production at its wholly-owned facility in Des Moines, Iowa as a result of the agreement with Elanco. Financial terms were not disclosed. 

Company Quote

0.62 +0.92%
9:33am EST